Pr Thomas Decaens
- Specialty
- Oncologist, liver expert
- Title
- Head of service
- Hospital
- Centre Hospitalier Université Grenoble Alpes (Grenoble)
- Latest articles
-
- Treatments for unresectable hepatocellular carcinoma: insights from CheckMate 9DW - Authors' reply. (Nov 22, 2025)
- Corrigendum to: "Evaluation of a delayed liver transplantation strategy for patients with HCC receiving bridging therapy: the DELTA-HCC study" [J Hepatol (2024) 278-288]. (Oct 27, 2025)
- A multicentric national phase II trial assessing TIslelizumab in monotherapy for patients with Hepatocellular Carcinoma Child-Pugh B and ALBI grade 1 or 2 liver function score: The UCGI 41 HESTIA TRIAL DESIGN AND PRELIMINARY SAFETY Data. (Oct 1, 2025)
- Real-World Outcomes of Atezolizumab-Bevacizumab in Hepatocellular Carcinoma: The Prospective French CHIEF Cohort. (Oct 1, 2025)
- Real-life data on hepatocellular carcinoma in the French prospective CHIEF cohort in the era of immunotherapy. (Sep 1, 2025)